BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21447515)

  • 21. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers.
    McFarland W; Gwanzura L; Bassett MT; Machekano R; Latif AS; Ley C; Parsonnet J; Burke RL; Katzenstein D
    J Infect Dis; 1999 Nov; 180(5):1459-65. PubMed ID: 10515804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial.
    Marrazzo JM; Rabe L; Kelly C; Richardson B; Deal C; Schwartz JL; Chirenje ZM; Piper J; Morrow RA; Hendrix CW; Marzinke MA; Hillier SL;
    J Infect Dis; 2019 May; 219(12):1940-1947. PubMed ID: 30753642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda.
    Serwadda D; Gray RH; Sewankambo NK; Wabwire-Mangen F; Chen MZ; Quinn TC; Lutalo T; Kiwanuka N; Kigozi G; Nalugoda F; Meehan MP; Ashley Morrow R; Wawer MJ
    J Infect Dis; 2003 Nov; 188(10):1492-7. PubMed ID: 14624374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women.
    Wald A; Langenberg AG; Link K; Izu AE; Ashley R; Warren T; Tyring S; Douglas JM; Corey L
    JAMA; 2001 Jun; 285(24):3100-6. PubMed ID: 11427138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition.
    Wald A; Krantz E; Selke S; Lairson E; Morrow RA; Zeh J
    J Infect Dis; 2006 Jul; 194(1):42-52. PubMed ID: 16741881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Socio-demographic and behavioural characteristics associated with HSV-2 sero-prevalence in high risk women in KwaZulu-Natal.
    Abbai NS; Wand H; Ramjee G
    BMC Res Notes; 2015 May; 8():185. PubMed ID: 25940115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.
    Langenberg AG; Corey L; Ashley RL; Leong WP; Straus SE
    N Engl J Med; 1999 Nov; 341(19):1432-8. PubMed ID: 10547406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women.
    Mavedzenge SN; Pol BV; Cheng H; Montgomery ET; Blanchard K; de Bruyn G; Ramjee G; Straten Av
    Sex Transm Dis; 2010 Jul; 37(7):460-6. PubMed ID: 20562586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing patients with genital herpes and their sexual partners.
    Patel R; Rompalo A
    Infect Dis Clin North Am; 2005 Jun; 19(2):427-38, x. PubMed ID: 15963881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization.
    Cherpes TL; Melan MA; Kant JA; Cosentino LA; Meyn LA; Hillier SL
    Clin Infect Dis; 2005 May; 40(10):1422-8. PubMed ID: 15844064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycoprotein-D-adjuvant vaccine to prevent genital herpes.
    Stanberry LR; Spruance SL; Cunningham AL; Bernstein DI; Mindel A; Sacks S; Tyring S; Aoki FY; Slaoui M; Denis M; Vandepapeliere P; Dubin G;
    N Engl J Med; 2002 Nov; 347(21):1652-61. PubMed ID: 12444179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
    Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M;
    N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.
    Ashley-Morrow R; Nollkamper J; Robinson NJ; Bishop N; Smith J
    Clin Microbiol Infect; 2004 Jun; 10(6):530-6. PubMed ID: 15191381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body mass index, sexual behaviour, and sexually transmitted infections: an analysis using the NHANES 1999-2000 data.
    Nagelkerke NJ; Bernsen RM; Sgaier SK; Jha P
    BMC Public Health; 2006 Aug; 6():199. PubMed ID: 16884541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial.
    Sawaya GF; Chirenje MZ; Magure MT; Tuveson JL; Ma Y; Shiboski SC; Da Costa MM; Palefsky JM; Moscicki AB; Mutasa RM; Chipato T; Smith-McCune KK
    Obstet Gynecol; 2008 Nov; 112(5):990-7. PubMed ID: 18978097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection.
    Abdool Karim SS; Abdool Karim Q; Kharsany AB; Baxter C; Grobler AC; Werner L; Kashuba A; Mansoor LE; Samsunder N; Mindel A; Gengiah TN;
    N Engl J Med; 2015 Aug; 373(6):530-9. PubMed ID: 26244306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya.
    Chohan V; Baeten JM; Benki S; Graham SM; Lavreys L; Mandaliya K; Ndinya-Achola JO; Jaoko W; Overbaugh J; McClelland RS
    Sex Transm Infect; 2009 Dec; 85(7):489-92. PubMed ID: 19457873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition.
    Martin ET; Krantz E; Gottlieb SL; Magaret AS; Langenberg A; Stanberry L; Kamb M; Wald A
    Arch Intern Med; 2009 Jul; 169(13):1233-40. PubMed ID: 19597073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diaphragm used with replens gel and risk of bacterial vaginosis: results from a randomized controlled trial.
    Cohen CR; Cheng SC; Shiboski S; Chipato T; Matu M; Mwangi J; Mutimutema ME; Tuveson J; Kamba M; Padian N; van der Straten A
    Infect Dis Obstet Gynecol; 2012; 2012():921519. PubMed ID: 23133307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa.
    Montgomery ET; Cheng H; van der Straten A; Chidanyika AC; Lince N; Blanchard K; Ramjee G; Nkala B; Padian NS;
    AIDS Behav; 2010 Jun; 14(3):629-38. PubMed ID: 19757018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.